Colgate Palmolive (CL) Notes Payables (2009 - 2026)

Colgate Palmolive's Notes Payables history runs 18 years deep, the most recent figure standing at $36.0 million for Q1 2026.

• On a quarterly basis, Notes Payables changed N/A year-over-year to $36.0 million in Q1 2026; TTM through Mar 2026 was $36.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 69.24% from the prior year.
• Notes Payables declined to $36.0 million in Q1 2026 per CL's latest filing, from $1.1 billion in the prior quarter.
• Across five years, Notes Payables topped out at $1.6 billion in Q2 2025 and bottomed at $7.0 million in Q1 2022.
• The 5-year median for Notes Payables is $183.0 million (2023), against an average of $407.1 million.
• Across the five-year window, Notes Payables sank 97.24% in 2022 and surged 2900.0% in 2023, its largest moves.
• Year by year, Notes Payables stood at $11.0 million in 2022, then jumped by 2900.0% to $330.0 million in 2023, then soared by 100.0% to $660.0 million in 2024, then soared by 69.24% to $1.1 billion in 2025, then sank by 96.78% to $36.0 million in 2026.
• Per Business Quant, the three latest CL Notes Payables figures stand at $36.0 million (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025).